Lakshmi Badrinarayanan1,2, Srujana Chitipothu3, Sharada Ramasubramanyan4, Sarangapani Sripriya5, Pukhraj Rishi6, Ekta Rishi6, Ronnie George7, Baddireddi Subhadra Lakshmi2, Sailaja V Elchuri1. 1. Department of Nano-biotechnology, KNBIRVO block, Vision Research Foundation, Chennai, Tamil Nadu 600006, India. 2. Department of Biotechnology, Anna University, Chennai, Tamil Nadu 600025, India. 3. Central Research Instrumentation Facility, KNBIRVO block, Vision Research Foundation, Chennai, Tamil Nadu 600006, India. 4. RS.Mehta Jain, Department of Biochemistry and Cell Biology, KNBIRVO block, Vision Research Foundation, Chennai, Tamil Nadu 600006, India. 5. SNONGC Department of Genetics and Molecular Biology, KNBIRVO block, Vision Research Foundation, Chennai, Tamil Nadu 600006, India. 6. Shri Bhagwan Mahavir Vitreo-Retinal Service, Medical Research Foundation, Chennai, Tamil Nadu 600006, India. 7. Smt. Jadhavbai Nathamal Singhree Glaucoma Service, Medical Research Foundation, Chennai, Tamil Nadu 600006, India.
Abstract
AIM: To access the association of forty-eight single nucleotide polymorphisms (SNPs) identified from Caucasian population with steroid-induced ocular hypertension (OHT) in India population. METHODS: Fifty-four triamcinolone-acetonide (TA) and forty-seven dexamethasone (Dex) administered subjects were enrolled in the study after a written consent. Intraocular pressure (IOP) values were recorded for a period of 6-month post steroid injections and patients were grouped as steroid-responders (SR: IOP≥21 mm Hg) and non-responders (NR: IOP≤20 mm Hg). Genomic DNA was isolated from peripheral venous blood. Forty-eight SNPs identified in TA treated Caucasian patients by genome wide association study (GWAS) were genotyped using iPLEX™ MassARRAY among TA as well as Dex administered Indian patients. Genotyping data of 48 general subjects from a previous study were considered as reference controls for statistical analysis. Genotypic frequencies were calculated and P-value, Chi-square and odds ratio at 95% confidence-interval of group A (steroid treated vs controls), group B (SR vs NR), group C (phenotype correlation: influence of time, severity and gender on IOP rise), were calculated. P<0.05 was considered to be statistically significant. RESULTS: OHT was observed in 50% of TA and 26% of Dex administered patients, respectively. IOP rise was mostly severe (>30 mm Hg) and immediate (<1wk) among TA-SR patients while it was noticed to be mild (<30 mm Hg) and between 1-2mo among Dex-SR patients. Logistic regression for risk factor correlation with OHT remained non-significant, hence these factors were not considered as confounding parameters for further analysis. rs133, rs34016742, rs274554, rs10936746, rs274547, rs804854, rs7751500, rs359498, and rs7547448 SNPs significantly varied even after Bonferroni corrections (P<0.0025; group A). rs1879370 (TA) and rs6559662 (Dex) were significantly (P<0.05) associated with OHT (group B). rs133 (severe IOP rise), rs11047639 and rs1879370 (male gender), and rs11171569 (immediate IOP rise) significantly (P<0.05) influenced the phenotype correlation only among TA-OHT patients. However, the significance of these SNPs in group B and phenotype analysis (group C) was lost upon Bonferroni corrections (P<0.0025). CONCLUSION: Prevalence of OHT in study population is observed to be similar to other studies both in TA and Dex treated patients. We can correlate rs34016742 involved in diabetes signaling pathway to the occurrence of ocular edematous and inflammatory conditions. Except rs133 that is involved in neuro-degeneration and myopia occurrence, none of the other SNPs identified in Caucasian population possess any correlation with OHT incidence in TA and Dex administered Indian subjects. International Journal of Ophthalmology Press.
AIM: To access the association of forty-eight single nucleotide polymorphisms (SNPs) identified from Caucasian population with steroid-induced ocular hypertension (OHT) in India population. METHODS: Fifty-four triamcinolone-acetonide (TA) and forty-seven dexamethasone (Dex) administered subjects were enrolled in the study after a written consent. Intraocular pressure (IOP) values were recorded for a period of 6-month post steroid injections and patients were grouped as steroid-responders (SR: IOP≥21 mm Hg) and non-responders (NR: IOP≤20 mm Hg). Genomic DNA was isolated from peripheral venous blood. Forty-eight SNPs identified in TA treated Caucasian patients by genome wide association study (GWAS) were genotyped using iPLEX™ MassARRAY among TA as well as Dex administered Indian patients. Genotyping data of 48 general subjects from a previous study were considered as reference controls for statistical analysis. Genotypic frequencies were calculated and P-value, Chi-square and odds ratio at 95% confidence-interval of group A (steroid treated vs controls), group B (SR vs NR), group C (phenotype correlation: influence of time, severity and gender on IOP rise), were calculated. P<0.05 was considered to be statistically significant. RESULTS: OHT was observed in 50% of TA and 26% of Dex administered patients, respectively. IOP rise was mostly severe (>30 mm Hg) and immediate (<1wk) among TA-SR patients while it was noticed to be mild (<30 mm Hg) and between 1-2mo among Dex-SR patients. Logistic regression for risk factor correlation with OHT remained non-significant, hence these factors were not considered as confounding parameters for further analysis. rs133, rs34016742, rs274554, rs10936746, rs274547, rs804854, rs7751500, rs359498, and rs7547448 SNPs significantly varied even after Bonferroni corrections (P<0.0025; group A). rs1879370 (TA) and rs6559662 (Dex) were significantly (P<0.05) associated with OHT (group B). rs133 (severe IOP rise), rs11047639 and rs1879370 (male gender), and rs11171569 (immediate IOP rise) significantly (P<0.05) influenced the phenotype correlation only among TA-OHT patients. However, the significance of these SNPs in group B and phenotype analysis (group C) was lost upon Bonferroni corrections (P<0.0025). CONCLUSION: Prevalence of OHT in study population is observed to be similar to other studies both in TA and Dex treated patients. We can correlate rs34016742 involved in diabetes signaling pathway to the occurrence of ocular edematous and inflammatory conditions. Except rs133 that is involved in neuro-degeneration and myopia occurrence, none of the other SNPs identified in Caucasian population possess any correlation with OHT incidence in TA and Dex administered Indian subjects. International Journal of Ophthalmology Press.
Authors: Dylan S Audette; Deepti Anand; Tammy So; Troy B Rubenstein; Salil A Lachke; Frank J Lovicu; Melinda K Duncan Journal: Development Date: 2015-12-10 Impact factor: 6.868
Authors: J H Fingert; A F Clark; J E Craig; W L Alward; G R Snibson; M McLaughlin; L Tuttle; D A Mackey; V C Sheffield; E M Stone Journal: Invest Ophthalmol Vis Sci Date: 2001-01 Impact factor: 4.799
Authors: Sabrina M Gerzenstein; Mathew T Pletcher; Alessandra C L Cervino; Nicholas F Tsinoremas; Brandon Young; Carmen A Puliafito; M Elizabeth Fini; Stephen G Schwartz Journal: Ophthalmic Genet Date: 2008-12 Impact factor: 1.803
Authors: Ramesh B Kasetti; Prabhavathi Maddineni; Pinkal D Patel; Charles Searby; Val C Sheffield; Gulab S Zode Journal: J Biol Chem Date: 2018-05-09 Impact factor: 5.157